VANI
Income statement / Annual
Last year (2024), Vivani Medical, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2024, Vivani Medical, Inc.'s net income was -$23.49 M.
See Vivani Medical, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$3.38 M |
$6.90 M |
$7.96 M |
$3.99 M |
$8.95 M |
| Cost of Revenue |
$0.00
|
$357.00 K
|
$0.00
|
$0.00
|
$0.00
|
$2.15 M
|
$4.89 M
|
$7.75 M
|
$9.35 M
|
$4.30 M
|
| Gross Profit |
$0.00
|
-$357.00 K
|
$0.00
|
$0.00
|
$0.00
|
$1.23 M
|
$2.01 M
|
$211.00 K
|
-$5.36 M
|
$4.65 M
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
0.36
|
0.29
|
0.03
|
-1.35
|
0.52
|
| Research and Development Expenses |
$15.75 M
|
$16.97 M
|
$14.17 M
|
$11.00 M
|
$6.87 M
|
$16.50 M
|
$10.21 M
|
$7.99 M
|
$5.35 M
|
$3.04 M
|
| General & Administrative Expenses |
$8.93 M
|
$10.00 M
|
$5.37 M
|
$2.32 M
|
$2.38 M
|
$9.23 M
|
$10.69 M
|
$10.93 M
|
$10.08 M
|
$8.22 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$6.10 M
|
$11.34 M
|
$9.57 M
|
$8.99 M
|
$8.94 M
|
| Selling, General & Administrative Expenses |
$8.93 M
|
$10.00 M
|
$5.37 M
|
$2.32 M
|
$2.38 M
|
$15.33 M
|
$26.63 M
|
$23.56 M
|
$21.77 M
|
$20.67 M
|
| Other Expenses |
$0.00
|
-$357.00 K
|
$1.70 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
-$2.64 M
|
$727.00 K
|
$991.00 K
|
| Operating Expenses |
$24.68 M
|
$26.61 M
|
$21.24 M
|
$13.32 M
|
$9.24 M
|
$31.82 M
|
$36.83 M
|
$28.92 M
|
$27.85 M
|
$24.70 M
|
| Cost And Expenses |
$24.68 M
|
$26.97 M
|
$21.24 M
|
$13.32 M
|
$9.24 M
|
$33.98 M
|
$41.72 M
|
$36.67 M
|
$37.20 M
|
$29.00 M
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$16.00 K
|
$362.00 K
|
$86.00 K
|
$93.00 K
|
$31.00 K
|
$2.00 K
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$29.00 K
|
| Depreciation & Amortization |
$400.00 K
|
$357.00 K
|
$381.00 K
|
$345.00 K
|
$354.00 K
|
$414.00 K
|
$435.00 K
|
$457.00 K
|
$432.00 K
|
$335.00 K
|
| EBITDA |
-$24.28 M |
-$25.30 M |
-$19.16 M |
-$12.98 M |
-$8.89 M |
-$33.18 M |
-$34.66 M |
-$28.06 M |
-$32.75 M |
-$19.68 M |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
-9.82
|
-5.03
|
-3.52
|
-8.22
|
-2.2
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
-9.06
|
-5.05
|
-3.6
|
-8.33
|
-2.24
|
| Total Other Income/Expenses Net |
$1.19 M
|
$1.31 M
|
$7.35 M
|
$550.00 K
|
-$36.00 K
|
-$3.00 M
|
-$269.00 K
|
$193.00 K
|
$31.00 K
|
$29.00 K
|
| Income Before Tax |
-$23.49 M
|
-$25.65 M
|
-$13.89 M
|
-$12.77 M
|
-$9.28 M
|
-$33.59 M
|
-$35.09 M
|
-$28.52 M
|
-$33.18 M
|
-$20.02 M
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
-9.94
|
-5.09
|
-3.58
|
-8.33
|
-2.24
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$86.00 K
|
$93.00 K
|
$31.00 K
|
$58.00 K
|
| Net Income |
-$23.49 M
|
-$25.65 M
|
-$13.89 M
|
-$12.77 M
|
-$9.28 M
|
-$33.59 M
|
-$35.09 M
|
-$28.52 M
|
-$33.18 M
|
-$20.02 M
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
-9.94
|
-5.09
|
-3.58
|
-8.33
|
-2.24
|
| EPS |
-0.43 |
-0.5 |
-0.17 |
-0.33 |
-0.33 |
-2.15 |
-4.08 |
-4.01 |
-5.99 |
-4.09 |
| EPS Diluted |
-0.43 |
-0.5 |
-0.17 |
-0.33 |
-0.33 |
-2.15 |
-4.08 |
-4.01 |
-5.99 |
-4.09 |
| Weighted Average Shares Out |
$54.98 M
|
$50.85 M
|
$38.24 M
|
$36.25 M
|
$28.11 M
|
$15.61 M
|
$8.60 M
|
$7.11 M
|
$5.54 M
|
$4.89 M
|
| Weighted Average Shares Out Diluted |
$54.98 M
|
$50.85 M
|
$38.24 M
|
$36.25 M
|
$28.11 M
|
$15.61 M
|
$8.60 M
|
$7.11 M
|
$5.54 M
|
$4.89 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
